Literature DB >> 11792046

Cerebral magnetic resonance imaging in a patient with ankylosing spondylitis and multiple sclerosis-like syndrome.

M Cellerini1, S Gabbrielli, S M Bongi.   

Abstract

Clinical and cerebral magnetic resonance imaging (MRI) findings in a patient with ankylosing spondylitis (AS) and multiple sclerosis-like (MS-like) syndrome are reported. Cerebral MRI demonstrated multiple, MS-like, scattered foci of signal abnormality, one of which showed contrast enhancement. Lesion dissemination in "space and time" is a hallmark for diagnosis of MS, and its demonstration by enhanced cerebral MRI prompted suspicion of coexistence of MS and AS in our patient.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11792046     DOI: 10.1007/s002340100619

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  5 in total

Review 1.  Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice.

Authors:  Cecilia Mercieca; Irene E van der Horst-Bruinsma; Andrew A Borg
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

2.  Occurrence of ankylosing spondylitis and multiple sclerosis-like syndrome in a HLA-B27 positive patient.

Authors:  Andrea Mignarri; Maria Teresa Dotti; Carla Battisti; Ignazio Vallone; Antonio Federico
Journal:  Neurol Sci       Date:  2009-05-15       Impact factor: 3.307

3.  Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.

Authors:  Uğur Uygunoğlu; Derya Uluduz; Koray Taşçılar; Sabahattin Saip
Journal:  Rheumatol Int       Date:  2012-12-27       Impact factor: 2.631

4.  Cerebral MRI lesions and anti-tumor necrosis factor-alpha therapy.

Authors:  Alexander Winkelmann; Robert Patejdl; Sabine Wagner; Reiner Benecke; Uwe Klaus Zettl
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

5.  Symptomatic noncompressive motoromyelopathy presents as early manifestation in ankylosing spondylitis.

Authors:  Wei-Hsi Chen; Hsin-Ling Yin; Hung-Sheng Lin; Chung-Jen Chen
Journal:  Rheumatol Int       Date:  2010-11-02       Impact factor: 3.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.